NM_000214.3:c.744A>G

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000214.3(JAG1):​c.744A>G​(p.Pro248Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0727 in 1,613,022 control chromosomes in the GnomAD database, including 4,713 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.068 ( 393 hom., cov: 32)
Exomes 𝑓: 0.073 ( 4320 hom. )

Consequence

JAG1
NM_000214.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.927
Variant links:
Genes affected
JAG1 (HGNC:6188): (jagged canonical Notch ligand 1) The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. [provided by RefSeq, Nov 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 20-10656409-T-C is Benign according to our data. Variant chr20-10656409-T-C is described in ClinVar as [Benign]. Clinvar id is 42482.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-10656409-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.927 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0892 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JAG1NM_000214.3 linkc.744A>G p.Pro248Pro synonymous_variant Exon 5 of 26 ENST00000254958.10 NP_000205.1 P78504-1Q99740

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JAG1ENST00000254958.10 linkc.744A>G p.Pro248Pro synonymous_variant Exon 5 of 26 1 NM_000214.3 ENSP00000254958.4 P78504-1
JAG1ENST00000423891.6 linkn.610A>G non_coding_transcript_exon_variant Exon 3 of 25 2

Frequencies

GnomAD3 genomes
AF:
0.0683
AC:
10392
AN:
152218
Hom.:
393
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0565
Gnomad AMI
AF:
0.0669
Gnomad AMR
AF:
0.0929
Gnomad ASJ
AF:
0.0121
Gnomad EAS
AF:
0.0142
Gnomad SAS
AF:
0.0503
Gnomad FIN
AF:
0.0796
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0770
Gnomad OTH
AF:
0.0579
GnomAD3 exomes
AF:
0.0723
AC:
18171
AN:
251246
Hom.:
798
AF XY:
0.0694
AC XY:
9430
AN XY:
135806
show subpopulations
Gnomad AFR exome
AF:
0.0577
Gnomad AMR exome
AF:
0.123
Gnomad ASJ exome
AF:
0.0104
Gnomad EAS exome
AF:
0.0116
Gnomad SAS exome
AF:
0.0598
Gnomad FIN exome
AF:
0.0837
Gnomad NFE exome
AF:
0.0759
Gnomad OTH exome
AF:
0.0637
GnomAD4 exome
AF:
0.0732
AC:
106913
AN:
1460686
Hom.:
4320
Cov.:
30
AF XY:
0.0720
AC XY:
52343
AN XY:
726724
show subpopulations
Gnomad4 AFR exome
AF:
0.0585
Gnomad4 AMR exome
AF:
0.121
Gnomad4 ASJ exome
AF:
0.0116
Gnomad4 EAS exome
AF:
0.0196
Gnomad4 SAS exome
AF:
0.0582
Gnomad4 FIN exome
AF:
0.0872
Gnomad4 NFE exome
AF:
0.0764
Gnomad4 OTH exome
AF:
0.0629
GnomAD4 genome
AF:
0.0683
AC:
10403
AN:
152336
Hom.:
393
Cov.:
32
AF XY:
0.0679
AC XY:
5059
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.0565
Gnomad4 AMR
AF:
0.0932
Gnomad4 ASJ
AF:
0.0121
Gnomad4 EAS
AF:
0.0145
Gnomad4 SAS
AF:
0.0503
Gnomad4 FIN
AF:
0.0796
Gnomad4 NFE
AF:
0.0770
Gnomad4 OTH
AF:
0.0573
Alfa
AF:
0.0661
Hom.:
636
Bravo
AF:
0.0681
Asia WGS
AF:
0.0420
AC:
145
AN:
3478
EpiCase
AF:
0.0671
EpiControl
AF:
0.0648

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 09, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 03, 2010
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Isolated Nonsyndromic Congenital Heart Disease Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Alagille syndrome due to a JAG1 point mutation Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 12, 2015
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
0.99
DANN
Benign
0.75
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10485741; hg19: chr20-10637057; COSMIC: COSV54757219; COSMIC: COSV54757219; API